Literature DB >> 11908261

Oligonephropathy: from a rare childhood disorder to a possible health problem in the adult.

Alfred Drukker1.   

Abstract

Recent data have shed significant new light on the structural and functional development of the kidneys, as well as on a rare congenital form of bilateral renal hypoplasia called congenital oligomeganephronia. In this renal disorder, few greatly enlarged and "hard-working" nephrons are found that will ultimately sclerose and lead to end-stage renal failure during early childhood. At the same time it has been recognized that the number of nephrons in the kidneys of various animal species and humans is correlated to renal mass. Therefore, premature babies and/or infants small for gestational age due to intrauterine malnutrition will be born with relatively small kidneys and a certain nephron deficit, a condition called congenital oligonephropathy. Extensive worldwide epidemiologic studies have now shown that these premature or SGA infants have a high incidence of cardiovascular disease, hypertension, hyperlipidemia, diabetes and renal failure in adulthood. Although the pathophysiologic mechanisms responsible for these complications of premature birth are not entirely understood, it has become clear that the described association may pose a possible health problem in the adult population. This review describes the background of COMN and CON as well as the evidence that has accumulated on the adult complications of the latter. In addition, some thoughts are presented on the importance of identifying subjects possibly affected by CON, such that early recognition may alter the ultimate outcome.

Entities:  

Mesh:

Year:  2002        PMID: 11908261

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  8 in total

Review 1.  The long-term renal and cardiovascular consequences of prematurity.

Authors:  Carolyn L Abitbol; Maria M Rodriguez
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

2.  Oligomeganephronia in an adult without end stage renal failure.

Authors:  Yoshinobu Fuke; Seiichiro Hemmi; Mamiko Kajiwara; Minako Yabuki; Takayuki Fujita; Masayoshi Soma
Journal:  Clin Exp Nephrol       Date:  2011-11-25       Impact factor: 2.801

3.  Age-related pathophysiological changes in rat oligomeganephronic hypoplastic kidney.

Authors:  Hiroetsu Suzuki; Tsuyoshi Tokuriki; Hideto Kamita; Chiharu Oota; Masaki Takasu; Kenichi Saito; Katsushi Suzuki
Journal:  Pediatr Nephrol       Date:  2006-03-30       Impact factor: 3.714

4.  Renal Function and Hematology in Rats with Congenital Renal Hypoplasia.

Authors:  Hidenori Yasuda; Kohei Amakasu; Yuki Tochigi; Kentaro Katayama; Hiroetsu Suzuki
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

5.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

6.  Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner.

Authors:  Joanna Cunanan; Erin Deacon; Kristina Cunanan; Zifan Yang; Antje Ask; Lily Morikawa; Ekaterina Todorova; Darren Bridgewater
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

Review 7.  A Case Report and Literature Review of Oligomeganephronia.

Authors:  Xu-Hao Wang; Lei Pan; Shan He; De-Lei Kong; Wei Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-22

8.  Heterozygous p.S811F RET gene mutation associated with renal agenesis, oligomeganephronia and total colonic aganglionosis: a case report.

Authors:  Keisuke Sugimoto; Tomoki Miyazawa; Hitomi Nishi; Kohei Miyazaki; Takuji Enya; Mitsuru Okada; Tsukasa Takemura
Journal:  BMC Nephrol       Date:  2016-10-07       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.